Review
Open access
Sep 2026
ABSTRACT Lateral flow assays (LFAs) remain central to point‐of‐care diagnostics because they combine low cost, portability, and operational simplicity. Emerging diagnostic demands, including low‐abundance biomarkers, complex sample matrices, quantitative readout, and multiplexed analysis, increasingly expose limitation...
Yan Pan, Yue-Wei Li, Chao Mi et al.
· Advancement of science · 0 citations